All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-T-1-M322-2 | Anti-MUC1 scFv h(CD28) CART, pCDCAR1 | Human | HMFG2 | Mouse | scFv-CD28 | Lentiviral | T cell | ||
CAR-T-1-M322-G | Anti-MUC1 scFv h(FcεRIγ) CART, pCDCAR1 | Human | HMFG2 | Mouse | scFv-FcεRIγ | Lentiviral | T cell | ||
CAR-T-1-M322-Z | Anti-MUC1 scFv h(CD3ζ) CART, pCDCAR1 | Human | HMFG2 | Mouse | scFv-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-M322-2G | Anti-MUC1 scFv h(CD28-FcεRIγ) CART, pCDCAR1 | Human | HMFG2 | Mouse | scFv-CD28-FcεRIγ | Lentiviral | T cell | ||
CAR-T-2-M322-2Z | Anti-MUC1 scFv h(CD28-CD3ζ) CART, pCDCAR1 | Human | HMFG2 | Mouse | scFv-CD28-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-M322-4G | Anti-MUC1 scFv h(CD4-FcεRIγ) CART, pCDCAR1 | Human | HMFG2 | Mouse | scFv-CD4-FcεRIγ | Lentiviral | T cell | ||
CAR-T-2-M322-4Z | Anti-MUC1 scFv h(CD4-CD3ζ) CART, pCDCAR1 | Human | HMFG2 | Mouse | scFv-CD4-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-M322-8Z | Anti-MUC1 scFv h(CD8-CD3ζ) CART, pCDCAR1 | Human | HMFG2 | Mouse | scFv-CD8-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-M322-BZ | Anti-MUC1 scFv h(41BB-CD3ζ) CART, pCDCAR1 | Human | HMFG2 | Mouse | scFv-41BB-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-M322-CZ | Anti-MUC1 scFv h(b2c-CD3ζ) CART, pCDCAR1 | Human | HMFG2 | Mouse | scFv-b2c-CD3ζ | Lentiviral | T cell | ||
CAR-T-3-M322-2BZ | Anti-MUC1 scFv h(CD28-41BB-CD3ζ) CART, pCDCAR1 | Human | HMFG2 | Mouse | scFv-CD28-41BB-CD3ζ | Lentiviral | T cell | ||
CAR-T-3-M322-2XZ | Anti-MUC1 scFv h(CD28-OX40-CD3ζ) CART, pCDCAR1 | Human | HMFG2 | Mouse | scFv-CD28-OX40-CD3ζ | Lentiviral | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION